NICE INSIGHT REPORT

Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 23 clinical and commercial cell therapy development and manufacturing RFP service line items
  • Exhaustive directory of capabilities profiles for the top 51 CDMOs specializing in cell therapy
  • MSC-based cell therapy project pricing study and an exploration of non-standardized manufacturing approaches
  • Technical focus on CAR-T, Stem Cells, Exosomes, MSCs, and iPSC-based therapies
Learn More
Cell Therapy

Key market intelligence for innovators, CDMOs and investors in the cell therapy market.

Exclusive CDMO pricing data for benchmarking

Measure your business against your peers using our robust analysis of the cell therapy contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure, and development process data from CDMOs all over the world so you can make informed decisions to best position your business.

Scientific analysis of cell therapies

The Cell Therapy Market Insight provides in-depth research into the current state of applications, development, and manufacturing of cell therapies, including allogeneic and autologous cell therapies. We provide you with essential information from innovators, CDMO owners, PhDs, and researchers across advanced therapeutics to fully understand cell therapies’ role in the future of healthcare.

Update cookies preferences